AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21673612 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycoconjugate vaccine (MenC-CRM group, n=95)
Number of subjects: 543
Study 21673612 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=298)
Number of subjects: 543
Study 18325740 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (32 mg/day)
Number of subjects: 20
Study 18325740 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 16571761 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-related activity for large-scale targets
Number of subjects: 0
Study 16571761 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention-related activity for small-scale targets
Number of subjects: 0
Study 12628548 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GR-1 and L. fermentum RC-14
Number of subjects: 64
Study 10234640 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A injections
Number of subjects: 20
Study 10234640 — intervention group
Group type: COMPARATOR
Intervention: Fixed plaster cast stretching
Number of subjects: 20
Study 8920846 — intervention group
Group type: EXPERIMENTAL
Intervention: Different manipulations of rod length in Experiment 1
Number of subjects: 49
Study 8920846 — intervention group
Group type: EXPERIMENTAL
Intervention: Wielding rods of two ranges (long and short) in Experiment 2
Number of subjects: 49
Study 8920846 — intervention group
Group type: EXPERIMENTAL
Intervention: Handling dense or light rods in Experiment 3
Number of subjects: 49
Study 1776539 — intervention group
Group type: EXPERIMENTAL
Intervention: sight and smell of the alcoholic beverage most commonly consumed by each subject
Number of subjects: 16
Study 1776539 — intervention group
Group type: EXPERIMENTAL
Intervention: sight and smell of preferred drink (20 presentations)
Number of subjects: 16
Study 7108667 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin followed immediately by furosemide
Number of subjects: 19
Study 7108667 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin alone
Number of subjects: 19
Study 31077873 — intervention group
Group type: EXPERIMENTAL
Intervention: KCNB2 rs349358 SNP
Number of subjects: 472
Study 31077873 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic risk score based on CHRM3 rs2165870 and KCNB2 rs349358 SNP
Number of subjects: 472
Study 31077873 — intervention group
Group type: EXPERIMENTAL
Intervention: Apfel Score
Number of subjects: 472
Study 31647774 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR t‐PBM (n=9)
Number of subjects: 18
Study 31647774 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR t‐PBM (n=6)
Number of subjects: 18
Study 31647774 — intervention group
Group type: COMPARATOR
Intervention: Sham (n=9)
Number of subjects: 18
Study 31647774 — intervention group
Group type: COMPARATOR
Intervention: Sham (n=8)
Number of subjects: 18
Study 28923758 — intervention group
Group type: EXPERIMENTAL
Intervention: Solo vibrating mesh nebulizer
Number of subjects: 15
Study 28923758 — intervention group
Group type: COMPARATOR
Intervention: Wright jet nebulizer
Number of subjects: 15
Study 28923758 — intervention group
Group type: EXPERIMENTAL
Intervention: Both nebulizers
Number of subjects: 15
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral for care during the early neonatal period (ENP: 0-7 days old)
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral for care during the late neonatal period (LNP: 8-28 days old)
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral reasons for boys during the ENP
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral reasons for girls during the ENP
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral reasons for boys during the LNP
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral reasons for girls during the LNP
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Care-seeking behavior for referred neonates
Number of subjects: 0
Study 26825276 — intervention group
Group type: EXPERIMENTAL
Intervention: Impact of family composition on care-seeking behavior
Number of subjects: 0
Study 23301548 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF) or emtricitabine (FTC)/TDF therapy
Number of subjects: 105
Study 23301548 — intervention group
Group type: COMPARATOR
Intervention: Wild-type HBV
Number of subjects: 105
Study 23301548 — intervention group
Group type: EXPERIMENTAL
Intervention: TDF or FTC/TDF therapy
Number of subjects: 105
Study 21973194 — intervention group
Group type: EXPERIMENTAL
Intervention: 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel
Number of subjects: 16
Study 21973194 — intervention group
Group type: COMPARATOR
Intervention: 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser monotherapy
Number of subjects: 16
Study 17681325 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified hMG
Number of subjects: 629
Study 17681325 — intervention group
Group type: COMPARATOR
Intervention: Recombinant FSH (rFSH)
Number of subjects: 629
Study 16505078 — intervention group
Group type: COMPARATOR
Intervention: R&S only (n = 315)
Number of subjects: 1202
Study 16505078 — intervention group
Group type: EXPERIMENTAL
Intervention: R&S + AaR (n = 284)
Number of subjects: 1202
Study 16505078 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group, n = 603)
Number of subjects: 1202
Study 15349912 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine 800 mg/d
Number of subjects: 43
Study 15349912 — intervention group
Group type: COMPARATOR
Intervention: Telbivudine (various doses: 25, 50, 100, 200, 400, and 800 mg/d)
Number of subjects: 43
Study 15349912 — intervention group
Group type: EXPERIMENTAL
Intervention: Telbivudine (400 mg/d or more)
Number of subjects: 43
Study 10759446 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised training on a treadmill, 4 days/week (group S; n=21)
Number of subjects: 41
Study 10759446 — intervention group
Group type: COMPARATOR
Intervention: Self-monitored walking 3 or 4 km in 1 hour, 4 days/week (group SM; n=20)
Number of subjects: 41
Study 8839087 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.25 mg.kg-1 intravenously (two doses)
Number of subjects: 200
Study 8839087 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 0.15 mg.kg-1 intravenously (two doses)
Number of subjects: 200
Study 8839087 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 1495854 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency jet ventilation (HFJV) with continued surfactant therapy
Number of subjects: 28
Study 1495854 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous surfactant therapy
Number of subjects: 28
Study 6379678 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg indoprofen 4-times daily
Number of subjects: 19
Study 6379678 — intervention group
Group type: COMPARATOR
Intervention: 25 mg indomethacin 4-times daily
Number of subjects: 19
Study 3527306 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (T)
Number of subjects: 210
Study 3527306 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen plus aminoglutethimide and hydrocortisone (T+AG+H)
Number of subjects: 210
Study 29402368 — intervention group
Group type: EXPERIMENTAL
Intervention: Humulin group
Number of subjects: 72
Study 29402368 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity group
Number of subjects: 72
Study 29402368 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity group
Number of subjects: 72
Study 29402368 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 72
Study 27115752 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel instrument used during operation in the experimental group
Number of subjects: 68
Study 27115752 — intervention group
Group type: COMPARATOR
Intervention: Control group (no novel instrument used)
Number of subjects: 68
Study 24856792 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching intervention for six weeks
Number of subjects: 49
Study 24856792 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 49
Study 22362927 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal disease (PD)
Number of subjects: 3416
Study 22362927 — intervention group
Group type: COMPARATOR
Intervention: No periodontal disease (PD)
Number of subjects: 3416
Study 22362927 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal disease (PD) in non-Caucasian women
Number of subjects: 3416
Study 22362927 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal disease (PD) in Caucasian women
Number of subjects: 3416
Study 20197607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (1.5 x 10^4 U/kg before CPB)
Number of subjects: 40
Study 20197607 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 18454224 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate 150 mg twice daily
Number of subjects: 45
Study 18454224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapsone 50 mg twice daily
Number of subjects: 45
Study 18454224 — intervention group
Group type: COMPARATOR
Intervention: Glucose 250 mg as placebo
Number of subjects: 45
Study 16170707 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarterial lipiodol application in Group A
Number of subjects: 36
Study 16170707 — intervention group
Group type: COMPARATOR
Intervention: Transarterial chemoembolization (TACE) in Group B
Number of subjects: 36
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal education
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Paternal education
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Miscarriage in previous pregnancy
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior child deaths
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger maternal mid-upper arm circumference
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: No tetanus vaccinations during pregnancy
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe illness during third trimester
Number of subjects: 15469
Study 14758431 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal mortality
Number of subjects: 15469
Study 18425652 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie restriction (1000-1200 kcal/day)
Number of subjects: 80
Study 18425652 — intervention group
Group type: COMPARATOR
Intervention: Dietary fat restriction (22-26 g/day)
Number of subjects: 80
Study 9198425 — intervention group
Group type: EXPERIMENTAL
Intervention: Cavit
Number of subjects: 51
Study 9198425 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate Restorative Material (IRM)
Number of subjects: 51
Study 9198425 — intervention group
Group type: EXPERIMENTAL
Intervention: TERM
Number of subjects: 51
Study 1753937 — intervention group
Group type: EXPERIMENTAL
Intervention: Local and systemic treatment with salcatonin
Number of subjects: 0
Study 6643769 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB monitor (sensitive to 300 nm)
Number of subjects: 0
Study 6643769 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA monitor (sensitive to 355 nm)
Number of subjects: 0
Study 6643769 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunlight exposure for rezeroing
Number of subjects: 0
Study 6643769 — intervention group
Group type: EXPERIMENTAL
Intervention: Sunlight-calibrated UVB monitor
Number of subjects: 0
Study 30676141 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Selected (SS)
Number of subjects: 16
Study 30676141 — intervention group
Group type: COMPARATOR
Intervention: 3 minute (3MIN)
Number of subjects: 16
Study 30676141 — intervention group
Group type: COMPARATOR
Intervention: 5 minute (5MIN)
Number of subjects: 16
Study 30676141 — intervention group
Group type: EXPERIMENTAL
Intervention: 3MIN, 5MIN, SS
Number of subjects: 16
Study 30815106 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithmic import of potentially missing child concepts evaluated by a human expert.
Number of subjects: 0
Study 30815106 — intervention group
Group type: COMPARATOR
Intervention: Human expert evaluation of child concepts.
Number of subjects: 0
Study 25950773 — intervention group
Group type: EXPERIMENTAL
Intervention: Health knowledge training program
Number of subjects: 22
Study 25950773 — intervention group
Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 22
Study 25322881 — intervention group
Group type: EXPERIMENTAL
Intervention: Education + Monitoring (n = 87)
Number of subjects: 137
Study 25322881 — intervention group
Group type: COMPARATOR
Intervention: Education Control (n = 50)
Number of subjects: 137
Study 22435320 — intervention group
Group type: EXPERIMENTAL
Intervention: Waterpik Water Flosser (WF) plus manual tooth brushing
Number of subjects: 82
Study 22435320 — intervention group
Group type: COMPARATOR
Intervention: Sonicare Air Floss (AF) plus manual tooth brushing
Number of subjects: 82
Study 20448327 — intervention group
Group type: EXPERIMENTAL
Intervention: Flextend Orthotic Exercise glove group
Number of subjects: 24
Study 20448327 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study 17580516 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine as adjunct to conventional treatment
Number of subjects: 0
Study 17580516 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0
Study 16145640 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 1.5 mg/kg added to 40 ml prilocaine 1.5%
Number of subjects: 60
Study 16145640 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 1.5 microg/kg added to 40 ml prilocaine 1.5%
Number of subjects: 60
Study 16145640 — intervention group
Group type: COMPARATOR
Intervention: Prilocaine 1.5% without additional medication (Control)
Number of subjects: 60
Study 11835111 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium profile (decreasing sodium concentration from 145 to 133 mmol/L)
Number of subjects: 9
Study 11835111 — intervention group
Group type: COMPARATOR
Intervention: Constant sodium concentration (138 mmol/L)
Number of subjects: 9
Study 11835111 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium profile (decreasing sodium concentration)
Number of subjects: 9
Study 11835111 — intervention group
Group type: COMPARATOR
Intervention: Constant sodium concentration
Number of subjects: 9
Study 11835111 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sodium profile and constant sodium concentration
Number of subjects: 9
Study 8982181 — intervention group
Group type: EXPERIMENTAL
Intervention: Perpendicular incisions to hair follicles
Number of subjects: 30
Study 8982181 — intervention group
Group type: COMPARATOR
Intervention: Parallel incisions to hair follicles
Number of subjects: 30
Study 8194628 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril therapy
Number of subjects: 0
Study 8194628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3307991 — intervention group
Group type: EXPERIMENTAL
Intervention: Medial incision of the anterior rectus sheath
Number of subjects: 360
Study 3307991 — intervention group
Group type: COMPARATOR
Intervention: Group A (standard lateral paramedian incision)
Number of subjects: 360
Study 3307991 — intervention group
Group type: COMPARATOR
Intervention: Group B (anterior sheath incised medially, posterior sheath incised laterally)
Number of subjects: 360
Study 3307991 — intervention group
Group type: COMPARATOR
Intervention: Group C (anterior sheath incised laterally, posterior sheath incised medially)
Number of subjects: 360
Study 31941445 — intervention group
Group type: EXPERIMENTAL
Intervention: Using social media to seek sexual partners
Number of subjects: 2006
Study 31941445 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing
Number of subjects: 2006
Study 31941445 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosing sexual orientation to a healthcare provider
Number of subjects: 2006
Study 31626156 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard therapy + VR (15 minutes twice daily for 10 days)
Number of subjects: 78
Study 31626156 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy only
Number of subjects: 78
Study 28629351 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQOL assessment considered important in daily work
Number of subjects: 1557
Study 28629351 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQOL assessment practices
Number of subjects: 1557
Study 28629351 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQOL assessment barriers
Number of subjects: 1557
Study 26289403 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Phone Resuscitation Guide (MPRG)
Number of subjects: 21
Study 26289403 — intervention group
Group type: COMPARATOR
Intervention: No MPRG (Control)
Number of subjects: 21
Study 23709583 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring and supervision by usual primary care clinicians of home self measured blood pressure with optional patient decision support for six months
Number of subjects: 401
Study 23709583 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 401
Study 23709583 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring intervention
Number of subjects: 401
Study 22204448 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic pediatric care between the 7th and 28th day of life
Number of subjects: 47
Study 22204448 — intervention group
Group type: COMPARATOR
Intervention: Control group (live-born infants with CL/P between 2001 and 2002)
Number of subjects: 47
Study 19704066 — intervention group
Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg/mo (plus 500 mg on day 14 of month 1)
Number of subjects: 205
Study 19704066 — intervention group
Group type: COMPARATOR
Intervention: Anastrozole 1 mg/d
Number of subjects: 205
Study 17273013 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender essential oil for inhalation
Number of subjects: 118
Study 17273013 — intervention group
Group type: COMPARATOR
Intervention: Inert oil (placebo) for inhalation
Number of subjects: 118
Study 15064923 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic patellofemoral brace (On‐Track System, dj Orthopedics) worn during all physical activities for 6 weeks
Number of subjects: 167
Study 15064923 — intervention group
Group type: COMPARATOR
Intervention: Control group (no brace) following the same 6-week training program
Number of subjects: 167
Study 11349180 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracervical placement of laminaria
Number of subjects: 50
Study 11349180 — intervention group
Group type: COMPARATOR
Intervention: Extra-amniotic saline solution infusion
Number of subjects: 50
Study 11349180 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 9159448 — intervention group
Group type: EXPERIMENTAL
Intervention: PR-A and PR-B immunohistochemistry
Number of subjects: 11
Study 9159448 — intervention group
Group type: EXPERIMENTAL
Intervention: Western blotting
Number of subjects: 11
Study 9159448 — intervention group
Group type: EXPERIMENTAL
Intervention: RNase protection assay
Number of subjects: 11
Study 8265095 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron
Number of subjects: 496
Study 8265095 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 mg ondansetron
Number of subjects: 496
Study 8265095 — intervention group
Group type: COMPARATOR
Intervention: 3 mg granisetron
Number of subjects: 496
Study 8265095 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 496
Study 3663434 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol 20 mg
Number of subjects: 0
Study 3663434 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol 30 mg
Number of subjects: 0
Study 3663434 — intervention group
Group type: EXPERIMENTAL
Intervention: Meptazinol 48 mg
Number of subjects: 0
Study 3663434 — intervention group
Group type: COMPARATOR
Intervention: Pethidine 20 mg
Number of subjects: 0
Study 29652755 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive treatment and rehabilitation program including preop chemotherapy, surgery, postop rehabilitation, and mesodiencephalic modulation (MDM) sessions after each invasive intervention.
Number of subjects: 21
Study 29652755 — intervention group
Group type: COMPARATOR
Intervention: Control group (details of intervention not specified).
Number of subjects: 21
Study 26481656 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid artery stenting (CAS)
Number of subjects: 115
Study 25485879 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative dexmedetomidine (1 μg kg(‐1) loading dose followed by 0.5 μg kg(‐1) h(‐1) continuous infusion)
Number of subjects: 109
Study 22922682 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor (loading dose 270 mg; 90 mg twice daily for 7 days) plus atorvastatin (80 mg on day 5)
Number of subjects: 48
Study 22922682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (loading dose 270 mg; 180 mg twice daily for 7 days) plus simvastatin (80 mg on day 5)
Number of subjects: 48
Study 22922682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor with atorvastatin metabolites
Number of subjects: 48
Study 22922682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor with simvastatin acid
Number of subjects: 48
Study 22922682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor (single dose)
Number of subjects: 48
Study 22029963 — intervention group
Group type: EXPERIMENTAL
Intervention: MTRX1011A at 1.5 mg/kg subcutaneously (s.c.) weekly
Number of subjects: 0
Study 22029963 — intervention group
Group type: EXPERIMENTAL
Intervention: MTRX1011A at 3.5 mg/kg s.c. weekly
Number of subjects: 0
Study 22029963 — intervention group
Group type: EXPERIMENTAL
Intervention: MTRX1011A at 5 mg/kg intravenously (i.v.) weekly
Number of subjects: 0
Study 22029963 — intervention group
Group type: COMPARATOR
Intervention: MTRX1011A (various doses)
Number of subjects: 0
Study 19103694 — intervention group
Group type: EXPERIMENTAL
Intervention: Andalusian Advance Directive Form (AADF)
Number of subjects: 171
Study 19103694 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative and deliberative sessions about end-of-life decision making
Number of subjects: 171
Study 19103694 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 171